Mouse models of heart failure: cell signaling and cell survival.
暂无分享,去创建一个
[1] Wei Huang,et al. &agr;B-Crystallin Modulates Protein Aggregation of Abnormal Desmin , 2003, Circulation research.
[2] G. King,et al. Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart. , 1999, Circulation.
[3] E. Alnemri,et al. Role of Omi/HtrA2 in Apoptotic Cell Death After Myocardial Ischemia and Reperfusion , 2005, Circulation.
[4] P. Ping,et al. Enhanced PKC beta II translocation and PKC beta II-RACK1 interactions in PKC epsilon-induced heart failure: a role for RACK1. , 2001, American journal of physiology. Heart and circulatory physiology.
[5] Dongyin Zhang,et al. Cardioprotective effects of exenatide against oxidative stress-induced injury. , 2013, International journal of molecular medicine.
[6] G. Bonne,et al. Striated muscle laminopathies. , 2014, Seminars in cell & developmental biology.
[7] Jeffrey Robbins,et al. A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy , 1998, Cell.
[8] Tong Zhang,et al. Transgenic CaMKII&dgr;C Overexpression Uniquely Alters Cardiac Myocyte Ca2+ Handling: Reduced SR Ca2+ Load and Activated SR Ca2+ Release , 2003, Circulation research.
[9] Frederick J. Schoen,et al. A Mouse Model of Familial Hypertrophic Cardiomyopathy , 1996, Science.
[10] P. Ping,et al. PKCε activation induces dichotomous cardiac phenotypes and modulates PKCε-RACK interactions and RACK expression , 2001 .
[11] G. Stone,et al. Relationship between myocardial reperfusion, infarct size, and mortality: the INFUSE-AMI (Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction) trial. , 2013, JACC. Cardiovascular interventions.
[12] Eric P. Hoffman,et al. Dystrophin: The protein product of the duchenne muscular dystrophy locus , 1987, Cell.
[13] Thomas M. Keane,et al. Mouse genomic variation and its effect on phenotypes and gene regulation , 2011, Nature.
[14] M. Eren,et al. Calmodulin kinase II inhibition protects against myocardial cell apoptosis in vivo. , 2006, American journal of physiology. Heart and circulatory physiology.
[15] H. Moser,et al. Duchenne muscular dystrophy: Pathogenetic aspects and genetic prevention , 2004, Human Genetics.
[16] P. Ellinor,et al. RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing , 2012, Nature Medicine.
[17] D. Kelsell,et al. Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma. , 2000, Human molecular genetics.
[18] D. Kass,et al. Combined TRPC3 and TRPC6 blockade by selective small-molecule or genetic deletion inhibits pathological cardiac hypertrophy , 2014, Proceedings of the National Academy of Sciences.
[19] Euan A. Ashley,et al. Patient-Specific Induced Pluripotent Stem Cells as a Model for Familial Dilated Cardiomyopathy , 2012, Science Translational Medicine.
[20] Tong Zhang,et al. Requirement for Ca2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice. , 2009, The Journal of clinical investigation.
[21] G. Dorn,et al. Protein Kinase C (cid:1) Negatively Regulates Systolic and Diastolic Function in Pathological Hypertrophy , 2022 .
[22] Lei Shi,et al. Structural and dynamic basis of phospholamban and sarcolipin inhibition of Ca(2+)-ATPase. , 2008, Biochemistry.
[23] C. Scheidereit,et al. The Prevalence of TNFα-Induced Necrosis over Apoptosis Is Determined by TAK1-RIP1 Interplay , 2011, PloS one.
[24] Young-Jae Nam,et al. The Mitochondrial Death Pathway and Cardiac Myocyte Apoptosis , 2004, Circulation research.
[25] R. Schwinger,et al. TNF and congestive heart failure: therapeutic possibilities , 2004, Expert opinion on therapeutic targets.
[26] P. Serruys,et al. Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival. , 1986, Journal of the American College of Cardiology.
[27] R. Lang,et al. Dilated cardiomyopathy in transgenic mice expressing a dominant-negative CREB transcription factor in the heart. , 1998, The Journal of clinical investigation.
[28] M. Prevost,et al. A missense mutation in the αB-crystallin chaperone gene causes a desmin-related myopathy , 1998, Nature Genetics.
[29] J. Seidman,et al. 5'RNA-Seq identifies Fhl1 as a genetic modifier in cardiomyopathy. , 2014, The Journal of clinical investigation.
[30] R. Kitsis,et al. Fas pathway is a critical mediator of cardiac myocyte death and MI during ischemia-reperfusion in vivo. , 2003, American journal of physiology. Heart and circulatory physiology.
[31] G. Dorn,et al. Transgenic Gαq overexpression induces cardiac contractile failure in mice , 1997 .
[32] I. Komuro,et al. p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload , 2007, Nature.
[33] G. Dorn,et al. Protein kinase cascades in the regulation of cardiac hypertrophy. , 2005, The Journal of clinical investigation.
[34] Yibin Wang. Mitogen-activated protein kinases in heart development and diseases. , 2007, Circulation.
[35] S. Vatner,et al. Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy. , 2003, The Journal of clinical investigation.
[36] Rick B. Vega,et al. Regulation of Cardiac Stress Signaling by Protein Kinase D1 , 2006, Molecular and Cellular Biology.
[37] Y. Ho,et al. Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice. , 2001, American journal of physiology. Heart and circulatory physiology.
[38] C. Hanis,et al. Genome-Wide Linkage and Admixture Mapping of Type 2 Diabetes in African American Families From the American Diabetes Association GENNID (Genetics of NIDDM) Study Cohort , 2009, Diabetes.
[39] E. Olson,et al. Calcium/Calmodulin-Dependent Protein Kinase II Contributes to Cardiac Arrhythmogenesis in Heart Failure , 2009, Circulation. Heart failure.
[40] M. Wheeler,et al. Cardiomyopathy is independent of skeletal muscle disease in muscular dystrophy , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[41] C. di Loreto,et al. Myocyte proliferation in end-stage cardiac failure in humans. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[42] S. Korsmeyer,et al. Inhibition of both the extrinsic and intrinsic death pathways through nonhomotypic death-fold interactions. , 2004, Molecular cell.
[43] D. Mann,et al. Left Ventricular Remodeling in Transgenic Mice With Cardiac Restricted Overexpression of Tumor Necrosis Factor , 2001, Circulation.
[44] D. Wagner,et al. The role of tumor necrosis factor in the pathophysiology of heart failure. , 2000, Journal of the American College of Cardiology.
[45] W. Robb MacLellan,et al. Systems-based approaches to cardiovascular disease , 2012, Nature Reviews Cardiology.
[46] J. Saffitz,et al. Desmin-related cardiomyopathy in transgenic mice: a cardiac amyloidosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[47] R. Lefkowitz,et al. Cardiac beta ARK1 inhibition prolongs survival and augments beta blocker therapy in a mouse model of severe heart failure. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[48] K. Davies,et al. Diaphragm rescue alone prevents heart dysfunction in dystrophic mice. , 2011, Human molecular genetics.
[49] D. Yellon,et al. Cyclosporin A and cardioprotection: from investigative tool to therapeutic agent , 2012, British journal of pharmacology.
[50] 中川 崇. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. , 2005 .
[51] A. Chawla,et al. Identification of Map4k4 as a Novel Suppressor of Skeletal Muscle Differentiation , 2012, Molecular and Cellular Biology.
[52] G Baumgarten,et al. Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[53] S. Wright. Pathophysiology of congestive heart failure , 1990, The Journal of cardiovascular nursing.
[54] G. Dorn,et al. ε Protein Kinase C in Pathological Myocardial Hypertrophy , 2000, The Journal of Biological Chemistry.
[55] M. Noseda,et al. Cardiopoietic factors: extracellular signals for cardiac lineage commitment. , 2011, Circulation research.
[56] O. H. Bing. Hypothesis: apoptosis may be a mechanism for the transition to heart failure with chronic pressure overload. , 1994, Journal of molecular and cellular cardiology.
[57] J. Chachques,et al. Animal models of heart failure: what is new? , 2005, The Annals of thoracic surgery.
[58] B. Moss,et al. A Role for Tumor Necrosis Factor Receptor-2 and Receptor-interacting Protein in Programmed Necrosis and Antiviral Responses* , 2003, Journal of Biological Chemistry.
[59] K. Vranizan,et al. Conditional expression of a Gi-coupled receptor causes ventricular conduction delay and a lethal cardiomyopathy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[60] D. Srivastava,et al. Cardiac fibroblasts regulate myocardial proliferation through beta1 integrin signaling. , 2009, Developmental cell.
[61] Joseph A. Hill,et al. Impaired Autophagosome Clearance Contributes to Cardiomyocyte Death in Ischemia/Reperfusion Injury , 2012, Circulation.
[62] M Rayner,et al. Cost of cardiovascular diseases in the United Kingdom , 2006, Heart.
[63] Xuejun Jiang,et al. Three-dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding, and activation. , 2002, Molecular cell.
[64] J. Ross,et al. Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[65] P. Robbins,et al. Soluble tumor necrosis factor receptor abrogates myocardial inflammation but not hypertrophy in cytokine-induced cardiomyopathy. , 2000, Circulation.
[66] M. Crackower,et al. Temporally Regulated and Tissue-Specific Gene Manipulations in the Adult and Embryonic Heart Using a Tamoxifen-Inducible Cre Protein , 2001, Circulation research.
[67] Jeffrey Robbins,et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death , 2005, Nature.
[68] W. Liu,et al. Journal of Cardiovascular Magnetic Resonance Open Access Early Manifestation of Alteration in Cardiac Function in Dystrophin Deficient Mdx Mouse Using 3d Cmr Tagging , 2009 .
[69] J. Inoue,et al. Recruitment of Tumor Necrosis Factor Receptor-associated Factor Family Proteins to Apoptosis Signal-regulating Kinase 1 Signalosome Is Essential for Oxidative Stress-induced Cell Death* , 2005, Journal of Biological Chemistry.
[70] V. Mootha,et al. tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. , 2000, Genes & development.
[71] M. Czech,et al. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes , 2008, Nature Reviews Molecular Cell Biology.
[72] R. Virmani,et al. Apoptosis in myocytes in end-stage heart failure. , 1996, The New England journal of medicine.
[73] T. Doetschman,et al. Cardiac-specific inducible and conditional gene targeting in mice. , 2012, Circulation research.
[74] G. Gibson,et al. Genetic Variation for Cardiac Dysfunction in Drosophila , 2007, PloS one.
[75] Joseph Avruch,et al. Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update. , 2012, Physiological reviews.
[76] I. Benjamin,et al. Autophagy is an adaptive response in desmin-related cardiomyopathy , 2007, Proceedings of the National Academy of Sciences.
[77] K. Campbell,et al. Disruption of the Sarcoglycan–Sarcospan Complex in Vascular Smooth Muscle A Novel Mechanism for Cardiomyopathy and Muscular Dystrophy , 1999, Cell.
[78] Yibin Wang,et al. The p38 mitogen-activated protein kinase pathway--a potential target for intervention in infarction, hypertrophy, and heart failure. , 2011, Journal of molecular and cellular cardiology.
[79] M. Martone,et al. Chronic Phospholamban–Sarcoplasmic Reticulum Calcium ATPase Interaction Is the Critical Calcium Cycling Defect in Dilated Cardiomyopathy , 1999, Cell.
[80] D. Mochly‐Rosen,et al. Reperfusion-Induced Translocation of &dgr;PKC to Cardiac Mitochondria Prevents Pyruvate Dehydrogenase Reactivation , 2005, Circulation research.
[81] K. Hizawa,et al. Life spans of Duchenne muscular dystrophy patients in the hospital care program in Japan , 1987, Journal of the Neurological Sciences.
[82] A. Harken,et al. Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1β , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[83] Chun Guo,et al. Absence of alpha 7 integrin in dystrophin-deficient mice causes a myopathy similar to Duchenne muscular dystrophy. , 2006, Human molecular genetics.
[84] Chun-Keung Yu,et al. Prostaglandin E2 promotes post-infarction cardiomyocyte replenishment by endogenous stem cells , 2014, EMBO molecular medicine.
[85] G. Dorn,et al. Inhibition of Cardiac Myocyte Apoptosis Improves Cardiac Function and Abolishes Mortality in the Peripartum Cardiomyopathy of G&agr;q Transgenic Mice , 2003, Circulation.
[86] I. Komuro,et al. ATF6 is important under both pathological and physiological states in the heart. , 2010, Journal of molecular and cellular cardiology.
[87] John W. Adams,et al. Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[88] Tomoki Nakamura,et al. Genetic approaches for changing the heart and dissecting complex syndromes. , 2008, Journal of molecular and cellular cardiology.
[89] T. Kita,et al. Activation of TGF-beta1-TAK1-p38 MAPK pathway in spared cardiomyocytes is involved in left ventricular remodeling after myocardial infarction in rats. , 2006, American journal of physiology. Heart and circulatory physiology.
[90] L. A. Anwer,et al. Cardiac SERCA2A/B: therapeutic targets for heart failure. , 2014, European journal of pharmacology.
[91] Nektarios Tavernarakis,et al. Functional and physical interaction between Bcl‐XL and a BH3‐like domain in Beclin‐1 , 2007, The EMBO journal.
[92] R. Hajjar,et al. CaMKII inhibition protects against necrosis and apoptosis in irreversible ischemia-reperfusion injury. , 2007, Cardiovascular research.
[93] Karen Ocorr,et al. A Global In Vivo Drosophila RNAi Screen Identifies NOT3 as a Conserved Regulator of Heart Function , 2010, Cell.
[94] B. Blaxall,et al. Phospholipase Cε Hydrolyzes Perinuclear Phosphatidylinositol 4-Phosphate to Regulate Cardiac Hypertrophy , 2013, Cell.
[95] P. Anversa,et al. End-stage cardiac failure in humans is coupled with the induction of proliferating cell nuclear antigen and nuclear mitotic division in ventricular myocytes. , 1994, Circulation research.
[96] Jing Chen,et al. Raf-1 promotes cell survival by antagonizing apoptosis signal-regulating kinase 1 through a MEK–ERK independent mechanism , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[97] J. Molkentin,et al. Temporal activation of c‐Jun N‐terminal kinase in adult transgenic heart via cre‐loxP‐mediated DNA recombination , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[98] Mutations in the human δ-sarcoglycan gene in familial and sporadic dilated cardiomyopathy , 2000 .
[99] J. Schaper,et al. Myocytes Die by Multiple Mechanisms in Failing Human Hearts , 2003, Circulation research.
[100] K. Zsebo,et al. Long-Term Effects of AAV1/SERCA2a Gene Transfer in Patients With Severe Heart Failure: Analysis of Recurrent Cardiovascular Events and Mortality , 2014, Circulation research.
[101] G. Dorn,et al. Intracellular transport mechanisms of signal transducers. , 2002, Annual review of physiology.
[102] C. Rubin,et al. Protein kinase D: coupling extracellular stimuli to the regulation of cell physiology , 2011, EMBO reports.
[103] D. Bernstein,et al. Deletion of the β2-adrenergic receptor prevents the development of cardiomyopathy in mice. , 2013, Journal of molecular and cellular cardiology.
[104] K. Toth,et al. Puma Deletion Delays Cardiac Dysfunction in Murine Heart Failure Models Through Attenuation of Apoptosis , 2011, Circulation.
[105] H. Tsui,et al. Pak1 as a Novel Therapeutic Target for Antihypertrophic Treatment in the Heart , 2011, Circulation.
[106] V. Kryštof,et al. Pharmacological targeting of CDK9 in cardiac hypertrophy , 2009, Medicinal research reviews.
[107] Minoru Hongo,et al. MLP-Deficient Mice Exhibit a Disruption of Cardiac Cytoarchitectural Organization, Dilated Cardiomyopathy, and Heart Failure , 1997, Cell.
[108] R. Kayed,et al. Exercise reverses preamyloid oligomer and prolongs survival in αB-crystallin-based desmin-related cardiomyopathy , 2007, Proceedings of the National Academy of Sciences.
[109] G. Danieli,et al. Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. , 2002, American journal of human genetics.
[110] R. Kayed,et al. Reversal of amyloid-induced heart disease in desmin-related cardiomyopathy. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[111] J. Sanes,et al. Skeletal and Cardiac Myopathies in Mice Lacking Utrophin and Dystrophin: A Model for Duchenne Muscular Dystrophy , 1997, Cell.
[112] Tetsuya Watanabe,et al. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death , 2005, Nature.
[113] Sangita Choudhury,et al. Moderate and high amounts of tamoxifen in αMHC-MerCreMer mice induce a DNA damage response, leading to heart failure and death , 2013, Disease Models & Mechanisms.
[114] Dimitrios Georgakopoulos,et al. The pathogenesis of familial hypertrophic cardiomyopathy: Early and evolving effects from an α-cardiac myosin heavy chain missense mutation , 1999, Nature Medicine.
[115] Herman I. May,et al. Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis , 2012, Nature.
[116] M. Entman,et al. Abstract 1949: The Protein Kinase MAP4K4 Is Activated in Failing Human Hearts and Mediates Cardiomyocyte Apoptosis in Experimental Models, in vitro and in vivo , 2007 .
[117] Yibin Wang,et al. Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. , 2010, Physiological reviews.
[118] G. Fishman,et al. Expression of protein kinase C beta in the heart causes hypertrophy in adult mice and sudden death in neonates. , 1997, The Journal of clinical investigation.
[119] G. Vorobiof,et al. Small Molecule Disruption of G&bgr;&ggr; Signaling Inhibits the Progression of Heart Failure , 2010, Circulation research.
[120] D. Mann,et al. Targeted Overexpression of Transmembrane Tumor Necrosis Factor Provokes a Concentric Cardiac Hypertrophic Phenotype , 2003, Circulation.
[121] F. Clubb,et al. Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. , 1998, Circulation.
[122] S. Vatner,et al. Cardiomyopathy induced by cardiac Gs alpha overexpression. , 1997, The American journal of physiology.
[123] Chetana Sachidanandan,et al. In vivo natriuretic peptide reporter assay identifies chemical modifiers of hypertrophic cardiomyopathy signalling. , 2012, Cardiovascular research.
[124] M. Periasamy,et al. Sarcolipin and phospholamban as regulators of cardiac sarcoplasmic reticulum Ca2+ ATPase. , 2007, Journal of molecular and cellular cardiology.
[125] J. Metzger,et al. Direct, Differential Effects of Tamoxifen, 4-Hydroxytamoxifen, and Raloxifene on Cardiac Myocyte Contractility and Calcium Handling , 2013, PloS one.
[126] G. Dorn,et al. Additive protection of the ischemic heart ex vivo by combined treatment with delta-protein kinase C inhibitor and epsilon-protein kinase C activator. , 2003, Circulation.
[127] R. Passier,et al. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. , 2000, The Journal of clinical investigation.
[128] A. Sanbe. Molecular mechanisms of α-crystallinopathy and its therapeutic strategy. , 2011, Biological & pharmaceutical bulletin.
[129] J. Seidman,et al. Altered cardiac excitation-contraction coupling in mutant mice with familial hypertrophic cardiomyopathy. , 1999, The Journal of clinical investigation.
[130] T. Asano,et al. Distinct Roles of Autophagy in the Heart During Ischemia and Reperfusion: Roles of AMP-Activated Protein Kinase and Beclin 1 in Mediating Autophagy , 2007, Circulation research.
[131] N. Maulik,et al. Bax ablation protects against myocardial ischemia-reperfusion injury in transgenic mice. , 2003, American journal of physiology. Heart and circulatory physiology.
[132] Stefan J Riedl,et al. A structure of the human apoptosome at 12.8 A resolution provides insights into this cell death platform. , 2005, Structure.
[133] I. Sjaastad,et al. Cre-loxP DNA recombination is possible with only minimal unspecific transcriptional changes and without cardiomyopathy in Tg(alphaMHC-MerCreMer) mice. , 2010, American journal of physiology. Heart and circulatory physiology.
[134] Stefanie Dimmeler,et al. Unchain my heart: the scientific foundations of cardiac repair. , 2005, The Journal of clinical investigation.
[135] T. Hewett,et al. Expression of R120G-alphaB-crystallin causes aberrant desmin and alphaB-crystallin aggregation and cardiomyopathy in mice. , 2001, Circulation research.
[136] Peter Scarborough,et al. EUROPEAN CARDIOVASCULAR DISEASE STATISTICS: THE EUROPEAN HEART HEALTH II (EUROHEART II) PROJECT , 2013 .
[137] C. Thompson,et al. Critical function of endogenous XIAP in regulating caspase activation during sympathetic neuronal apoptosis , 2003, The Journal of cell biology.
[138] Y. Pinto,et al. Avoidance of Transient Cardiomyopathy in Cardiomyocyte-Targeted Tamoxifen-Induced MerCreMer Gene Deletion Models , 2009, Circulation research.
[139] J. Molkentin,et al. ASK1 Regulates Cardiomyocyte Death but Not Hypertrophy in Transgenic Mice , 2009, Circulation research.
[140] G. Dorn,et al. Cardiotrophic Effects of Protein Kinase C ε Analysis by In Vivo Modulation of PKCε Translocation , 2000 .
[141] L. Leinwand,et al. Mice Expressing Mutant Myosin Heavy Chains Are a Model for Familial Hypertrophic Cardiomyopathy , 1996, Molecular medicine.
[142] Dean P. Jones,et al. The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore , 2004, Nature.
[143] D. Burkin,et al. Severe muscular dystrophy in mice that lack dystrophin and α7 integrin , 2006, Journal of Cell Science.
[144] Simon C Watkins,et al. Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[145] D. Mann,et al. Targeted Overexpression of Noncleavable and Secreted Forms of Tumor Necrosis Factor Provokes Disparate Cardiac Phenotypes , 2004, Circulation.
[146] E. Olson,et al. Dilated Cardiomyopathy and Sudden Death Resulting From Constitutive Activation of Protein Kinase A , 2001, Circulation research.
[147] Tao Wang,et al. Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-α , 2009, Cell.
[148] Donald M Bers,et al. Drug Screening Using a Library of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes Reveals Disease-Specific Patterns of Cardiotoxicity , 2013, Circulation.
[149] H. Goebel,et al. Desmin pathology in neuromuscular diseases , 1993, Virchows Archiv. B, Cell pathology including molecular pathology.
[150] Roger R Markwald,et al. Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β. , 2010, The Journal of clinical investigation.
[151] J. Mate,et al. A dysfunctional desmin mutation in a patient with severe generalized myopathy. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[152] D. Rosenbaum,et al. Targeted Activation of c-Jun N-terminal Kinase in Vivo Induces Restrictive Cardiomyopathy and Conduction Defects*[boxs] , 2004, Journal of Biological Chemistry.
[153] Cristiano R. W. Guimaraes,et al. Understanding the Impact of the P-loop Conformation on Kinase Selectivity , 2011, J. Chem. Inf. Model..
[154] J. Robbins,et al. Manipulation of Death Pathways in Desmin-Related Cardiomyopathy , 2010, Circulation research.
[155] K. Mani,et al. The Apoptosis Inhibitor ARC Undergoes Ubiquitin-Proteasomal-mediated Degradation in Response to Death Stimuli , 2007, Journal of Biological Chemistry.
[156] M. Lohse,et al. A Role for Caspase-1 in Heart Failure , 2007, Circulation research.
[157] Barry Greenberg,et al. Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): A Phase 2 Trial of Intracoronary Gene Therapy of Sarcoplasmic Reticulum Ca2+-ATPase in Patients With Advanced Heart Failure , 2011, Circulation.
[158] Kalyani V. P. Guntur,et al. Tumor necrosis factor alpha (TNFalpha) stimulates Map4k4 expression through TNFalpha receptor 1 signaling to c-Jun and activating transcription factor 2. , 2007, The Journal of biological chemistry.
[159] S. Kaneko,et al. Muscle-Specific RING Finger 1 Negatively Regulates Pathological Cardiac Hypertrophy Through Downregulation of Calcineurin A , 2014, Circulation. Heart failure.
[160] Paul A. Overbeek,et al. TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice , 2000, Nature Medicine.
[161] K. Fukunaga,et al. Inhibition of HtrA2/Omi ameliorates heart dysfunction following ischemia/reperfusion injury in rat heart in vivo. , 2007, European journal of pharmacology.
[162] J. Beckmann,et al. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. , 1998, Immunity.
[163] A. Protopopov,et al. Role of Telomere Dysfunction in Cardiac Failure in Duchenne Muscular Dystrophy , 2013, Nature Cell Biology.
[164] E. Murphy,et al. Mitochondrial Dysfunction and Apoptosis Underlie the Pathogenic Process in α-B-Crystallin Desmin-Related Cardiomyopathy , 2005, Circulation.
[165] K. Clarke,et al. Molecular Mechanism of the E99K Mutation in Cardiac Actin (ACTC Gene) That Causes Apical Hypertrophy in Man and Mouse* , 2011, The Journal of Biological Chemistry.
[166] J. Molkentin,et al. Signaling effectors underlying pathologic growth and remodeling of the heart. , 2013, The Journal of clinical investigation.
[167] A. Ashworth,et al. Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart. p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion. , 1996, Circulation research.
[168] J. Seidman,et al. Genetics of congenital heart disease: the glass half empty. , 2013, Circulation research.
[169] L. Rubin,et al. A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS. , 2013, Cell stem cell.
[170] Samuel Bernard,et al. Evidence for Cardiomyocyte Renewal in Humans , 2008, Science.
[171] S. Allender,et al. Coronary heart disease statistics. , 2008 .
[172] Michael D. Schneider,et al. Telomere attrition and Chk2 activation in human heart failure , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[173] R. Kitsis,et al. Cell death in the pathogenesis of heart disease: mechanisms and significance. , 2010, Annual review of physiology.
[174] P. Croisille,et al. Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction. , 2010, Journal of the American College of Cardiology.
[175] A. Hatzopoulos,et al. Cardiac repair and regeneration: the Rubik’s cube of cell therapy for heart disease , 2009, Disease Models & Mechanisms.
[176] G. Häcker,et al. cIAPs Block Ripoptosome Formation, a RIP1/Caspase-8 Containing Intracellular Cell Death Complex Differentially Regulated by cFLIP Isoforms , 2011, Molecular cell.
[177] V. Chapman,et al. Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[178] J. Miyazaki,et al. Cardiac-specific disruption of the c-raf-1 gene induces cardiac dysfunction and apoptosis. , 2004, The Journal of clinical investigation.
[179] R. Gottlieb,et al. Autophagy during cardiac stress: joys and frustrations of autophagy. , 2010, Annual review of physiology.
[180] M J Davies,et al. Apoptotic versus autophagic cell death in heart failure. , 2001, Cardiovascular research.
[181] Tong Zhang,et al. The &dgr;C Isoform of CaMKII Is Activated in Cardiac Hypertrophy and Induces Dilated Cardiomyopathy and Heart Failure , 2003, Circulation research.
[182] D. Yellon,et al. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. , 2013, The Journal of clinical investigation.
[183] U. Smith,et al. Impaired Preadipocyte Differentiation in Human Abdominal Obesity , 2009, Diabetes.
[184] Jeffrey Robbins,et al. With great power comes great responsibility: using mouse genetics to study cardiac hypertrophy and failure. , 2009, Journal of molecular and cellular cardiology.
[185] J C Reed,et al. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. , 1998, Science.
[186] Michael D. Schneider,et al. Transgenic Expression of Bcl-2 Modulates Energy Metabolism, Prevents Cytosolic Acidification During Ischemia, and Reduces Ischemia/Reperfusion Injury , 2004, Circulation research.
[187] Jong-Sun Kang,et al. TGF-β-activated Kinase 1 (TAK1) and Apoptosis Signal-regulating Kinase 1 (ASK1) Interact with the Promyogenic Receptor Cdo to Promote Myogenic Differentiation via Activation of p38MAPK Pathway* , 2012, The Journal of Biological Chemistry.
[188] H Sugita,et al. Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies. , 1991, American journal of human genetics.
[189] M. Cho,et al. Defective β-Adrenergic Receptor Signaling Precedes the Development of Dilated Cardiomyopathy in Transgenic Mice with Calsequestrin Overexpression* , 1999, The Journal of Biological Chemistry.
[190] T. Hewett,et al. Transgenic modeling of a cardiac troponin I mutation linked to familial hypertrophic cardiomyopathy. , 2000, Circulation research.
[191] Q. Chen,et al. Hydrogen peroxide dose dependent induction of cell death or hypertrophy in cardiomyocytes. , 2000, Archives of biochemistry and biophysics.
[192] Francis G Spinale,et al. Animal models of heart failure: a scientific statement from the American Heart Association. , 2012, Circulation research.
[193] C A Beltrami,et al. Apoptosis in the failing human heart. , 1997, The New England journal of medicine.
[194] A. Koretsky,et al. Dilated Cardiomyopathy in Transgenic Mice With Cardiac-Specific Overexpression of Tumor Necrosis Factor-α , 1997 .
[195] K. Davies,et al. In vivo MRI Characterization of Progressive Cardiac Dysfunction in the mdx Mouse Model of Muscular Dystrophy , 2012, PloS one.
[196] M. Todaro,et al. Heart-targeted overexpression of caspase3 in mice increases infarct size and depresses cardiac function , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[197] Nico Van de Veire. European Cardiovascular Disease Statistics 4 th edition 2012 : EuroHeart II , .
[198] I. Piña,et al. Forecasting the Impact of Heart Failure in the United States: A Policy Statement From the American Heart Association , 2013, Circulation. Heart failure.
[199] J. Towbin,et al. Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. , 2000, The Journal of clinical investigation.
[200] P. Halban,et al. Silencing Mitogen-activated Protein 4 Kinase 4 (MAP4K4) Protects Beta Cells from Tumor Necrosis Factor-α-induced Decrease of IRS-2 and Inhibition of Glucose-stimulated Insulin Secretion* , 2009, The Journal of Biological Chemistry.
[201] Mi-Sung Kim,et al. Requirement of protein kinase D1 for pathological cardiac remodeling , 2008, Proceedings of the National Academy of Sciences.
[202] G. Dorn,et al. Epsilon protein kinase C in pathological myocardial hypertrophy. Analysis by combined transgenic expression of translocation modifiers and Galphaq. , 2000, The Journal of biological chemistry.
[203] Jason T. Su,et al. Evidence for a dystrophin missense mutation as a cause of X-linked dilated cardiomyopathy. , 1997, Circulation.
[204] G. Dorn,et al. Mitochondrial death protein Nix is induced in cardiac hypertrophy and triggers apoptotic cardiomyopathy , 2002, Nature Medicine.
[205] Ke Chen,et al. IRF8 suppresses pathological cardiac remodelling by inhibiting calcineurin signalling , 2014, Nature Communications.
[206] A. Halestrap,et al. Sanglifehrin A Acts as a Potent Inhibitor of the Mitochondrial Permeability Transition and Reperfusion Injury of the Heart by Binding to Cyclophilin-D at a Different Site from Cyclosporin A* , 2002, The Journal of Biological Chemistry.
[207] P. Ping,et al. PKCepsilon activation induces dichotomous cardiac phenotypes and modulates PKCepsilon-RACK interactions and RACK expression. , 2001, American journal of physiology. Heart and circulatory physiology.
[208] P. Burridge,et al. A Review of Human Pluripotent Stem Cell-Derived Cardiomyocytes for High-Throughput Drug Discovery, Cardiotoxicity Screening, and Publication Standards , 2013, Journal of Cardiovascular Translational Research.
[209] Xiaodong Wang,et al. TNF-α Induces Two Distinct Caspase-8 Activation Pathways , 2008, Cell.
[210] Y. Lin,et al. Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. , 1999, Genes & development.
[211] Q. Liang,et al. Reengineering Inducible Cardiac-Specific Transgenesis With an Attenuated Myosin Heavy Chain Promoter , 2003, Circulation research.
[212] Michael D. Schneider,et al. The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function , 2006, Nature Immunology.
[213] R. Gottlieb,et al. Functional and clinical repercussions of myocyte apoptosis in the multifaceted damage by ischemia/reperfusion injury: old and new concepts after 10 years of contributions , 2004, Cell Death and Differentiation.
[214] Liza S. M. Wong,et al. Telomere biology in cardiovascular disease: the TERC-/- mouse as a model for heart failure and ageing. , 2008, Cardiovascular research.
[215] Brian Seed,et al. Fas triggers an alternative, caspase-8–independent cell death pathway using the kinase RIP as effector molecule , 2000, Nature Immunology.
[216] J. Seidman,et al. Electrophysiological abnormalities and arrhythmias in alpha MHC mutant familial hypertrophic cardiomyopathy mice. , 1997, The Journal of clinical investigation.
[217] T. Hewett,et al. Ca2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure. , 2007, The Journal of clinical investigation.
[218] D. Burkin,et al. Severe muscular dystrophy in mice that lack dystrophin and alpha7 integrin. , 2006, Journal of cell science.
[219] G. Dorn,et al. Interactions Between Phospholamban and &bgr;-Adrenergic Drive May Lead to Cardiomyopathy and Early Mortality , 2001, Circulation.
[220] F. Muntoni,et al. Brief report: deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. , 1993, The New England journal of medicine.
[221] M. Prevost,et al. Bcl-2 and Bax modulate adenine nucleotide translocase activity. , 2003, Cancer research.
[222] D. Mancini,et al. Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial. , 2009, Journal of cardiac failure.
[223] W. Craigen,et al. Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death , 2007, Nature Cell Biology.
[224] Masashi Narita,et al. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC , 1999, Nature.
[225] S. Korsmeyer,et al. VDAC2 Inhibits BAK Activation and Mitochondrial Apoptosis , 2003, Science.
[226] Christoph Preuss,et al. Genetics of heart failure in congenital heart disease. , 2013, The Canadian journal of cardiology.
[227] Michael D. Schneider,et al. Cardiac muscle regeneration: lessons from development. , 2011, Genes & development.
[228] M. Schulze,et al. Association of Common Genetic Variants in the MAP4K4 Locus with Prediabetic Traits in Humans , 2012, PloS one.
[229] J. McMurray,et al. Targeted Anticytokine Therapy in Patients With Chronic Heart Failure: Results of the Randomized Etanercept Worldwide Evaluation (RENEWAL) , 2004, Circulation.
[230] M. Mocanu,et al. The Cardioprotective Effect of Necrostatin Requires the Cyclophilin-D Component of the Mitochondrial Permeability Transition Pore , 2007, Cardiovascular Drugs and Therapy.
[231] Jonathan Seidman,et al. Genetic causes of human heart failure. , 2005, The Journal of clinical investigation.
[232] D. Duan,et al. Partial restoration of cardiac function with ΔPDZ nNOS in aged mdx model of Duchenne cardiomyopathy. , 2014, Human molecular genetics.
[233] T. Hewett,et al. Expression of R120G–αB-Crystallin Causes Aberrant Desmin and αB-Crystallin Aggregation and Cardiomyopathy in Mice , 2001 .
[234] K. Moore,et al. X chromosome-linked muscular dystrophy (mdx) in the mouse. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[235] H. Schulman,et al. Disease mechanisms and emerging therapies: protein kinases and their inhibitors in myocardial disease , 2006, Nature Clinical Practice Cardiovascular Medicine.
[236] Douglas L. Mann,et al. Heart Failure: a Companion to Braunwald's Heart Disease , 2014 .
[237] James O. Mudd,et al. An abnormal Ca2+ response in mutant sarcomere protein–mediated familial hypertrophic cardiomyopathy , 2000 .
[238] M. Lotze,et al. The Beclin 1 network regulates autophagy and apoptosis , 2011, Cell Death and Differentiation.
[239] M. Gautel,et al. Protein Kinase D Is a Novel Mediator of Cardiac Troponin I Phosphorylation and Regulates Myofilament Function , 2004, Circulation research.
[240] D. Goeddel,et al. Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. , 2000, Immunity.
[241] L. Masterson,et al. Structural and Dynamic Basis of Phospholamban and Sarcolipin Inhibition of Ca2+-ATPase† , 2008 .
[242] D. Mann,et al. Cardiac myocyte apoptosis provokes adverse cardiac remodeling in transgenic mice with targeted TNF overexpression. , 2004, American journal of physiology. Heart and circulatory physiology.
[243] E. Rozengurt,et al. Expression and activity of protein kinase D/protein kinase C mu in myocardium: evidence for alpha1-adrenergic receptor- and protein kinase C-mediated regulation. , 2000, Journal of molecular and cellular cardiology.
[244] S. Sengupta,et al. Role of α-crystallin B as a regulatory switch in modulating cardiomyocyte apoptosis by mitochondria or endoplasmic reticulum during cardiac hypertrophy and myocardial infarction , 2013, Cell Death and Disease.
[245] M. Xie,et al. Phosphorylation of Thr-178 and Thr-184 in the TAK1 T-loop Is Required for Interleukin (IL)-1-mediated Optimal NFκB and AP-1 Activation as Well as IL-6 Gene Expression* , 2008, Journal of Biological Chemistry.
[246] J. Towbin,et al. X‐Linked Dilated Cardiomyopathy Molecular Genetic Evidence of Linkage to the Duchenne Muscular Dystrophy (Dystrophin) Gene at the Xp21 Locus , 1993, Circulation.
[247] L. Leinwand,et al. Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy. , 2001, The Journal of clinical investigation.
[248] J. Schaper,et al. Progression From Compensated Hypertrophy to Failure in the Pressure-Overloaded Human Heart: Structural Deterioration and Compensatory Mechanisms , 2003, Circulation.
[249] L. Mestroni,et al. Dystrophin gene abnormalities in two patients with idiopathic dilated cardiomyopathy , 1997, Heart.
[250] S. Cook,et al. Are transgenic mice the 'alkahest' to understanding myocardial hypertrophy and failure? , 2009, Journal of molecular and cellular cardiology.
[251] G. Dorn,et al. Cardiotrophic effects of protein kinase C epsilon: analysis by in vivo modulation of PKCepsilon translocation. , 2000, Circulation research.
[252] M. Morad,et al. Regulation of Ca2+ signaling in transgenic mouse cardiac myocytes overexpressing calsequestrin. , 1998, The Journal of clinical investigation.
[253] B. Levine,et al. The autophagy effector Beclin 1: a novel BH3-only protein , 2008, Oncogene.
[254] K. Kariya,et al. Mitogen-activated Protein Kinase Kinase Kinase Kinase 4 as a Putative Effector of Rap2 to Activate the c-Jun N-terminal Kinase* , 2004, Journal of Biological Chemistry.
[255] G. Dorn,et al. Dual autonomous mitochondrial cell death pathways are activated by Nix/BNip3L and induce cardiomyopathy , 2010, Proceedings of the National Academy of Sciences.
[256] E. Kranias,et al. From mouse to man: understanding heart failure through genetically altered mouse models. , 2002, Journal of cardiac failure.
[257] J. Molkentin,et al. Developing small molecules to inhibit kinases unkind to the heart: p38 MAPK as a case in point. , 2010, Drug discovery today. Disease mechanisms.
[258] G. King,et al. Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[259] L. Tesson,et al. Generation of TALEN-Mediated GRdim Knock-In Rats by Homologous Recombination , 2014, PloS one.
[260] James O. Mudd,et al. An abnormal Ca(2+) response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy. , 2000, The Journal of clinical investigation.
[261] L. Leinwand,et al. Progression from hypertrophic to dilated cardiomyopathy in mice that express a mutant myosin transgene. , 2001, American journal of physiology. Heart and circulatory physiology.
[262] N. Maeda,et al. The role of natriuretic peptides in cardioprotection. , 2006, Cardiovascular research.
[263] J. Robbins,et al. Cardiomyocyte Expression of a Polyglutamine Preamyloid Oligomer Causes Heart Failure , 2008, Circulation.
[264] J. Richardson,et al. Cardiac autophagy is a maladaptive response to hemodynamic stress. , 2007, The Journal of clinical investigation.
[265] M. Czech,et al. Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation , 2009, Nature.
[266] V. Chapman,et al. The Frequency of Revertants in mdx Mouse Genetic Models for Duchenne Muscular Dystrophy , 1992, Pediatric Research.
[267] Michael D. Schneider,et al. TNF provokes cardiomyocyte apoptosis and cardiac remodeling through activation of multiple cell death pathways. , 2007, The Journal of clinical investigation.
[268] R. Lefkowitz,et al. Cardiac βARK1 inhibition prolongs survival and augments β blocker therapy in a mouse model of severe heart failure , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[269] C. Barbas,et al. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. , 2013, Trends in biotechnology.
[270] J. Slightom,et al. Differential expression of dystrophin isoforms in strains of mdx mice with different mutations. , 1996, Human molecular genetics.
[271] Rick B. Vega,et al. Protein Kinases C and D Mediate Agonist-Dependent Cardiac Hypertrophy through Nuclear Export of Histone Deacetylase 5 , 2004, Molecular and Cellular Biology.
[272] T. Kita,et al. Activation of TGF-β1-TAK1-p38 MAPK pathway in spared cardiomyocytes is involved in left ventricular remodeling after myocardial infarction in rats , 2006 .
[273] P. Anversa,et al. A matter of life and death: cardiac myocyte apoptosis and regeneration. , 2003, The Journal of clinical investigation.
[274] Guey-Shin Wang,et al. PKC inhibition ameliorates the cardiac phenotype in a mouse model of myotonic dystrophy type 1. , 2009, The Journal of clinical investigation.
[275] Jiahuai Han,et al. Cardiac Hypertrophy Induced by Mitogen-activated Protein Kinase Kinase 7, a Specific Activator for c-Jun NH2-terminal Kinase in Ventricular Muscle Cells* , 1998, The Journal of Biological Chemistry.
[276] H. Sweeney,et al. Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy , 2008, Nature Medicine.
[277] A. Feldman,et al. Phospholamban gene ablation improves calcium transients but not cardiac function in a heart failure model. , 2004, Cardiovascular research.
[278] S. Akira,et al. Mitochondrial DNA That Escapes from Autophagy Causes Inflammation and Heart Failure , 2012, Nature.
[279] M. Rudnicki,et al. Severe cardiomyopathy in mice lacking dystrophin and MyoD. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[280] M. Peter. The flip side of FLIP. , 2004, The Biochemical journal.
[281] P. Doevendans,et al. Targeting cell death in the reperfused heart: pharmacological approaches for cardioprotection. , 2013, International journal of cardiology.
[282] Y. Capetanaki,et al. Disruption of muscle architecture and myocardial degeneration in mice lacking desmin , 1996, The Journal of cell biology.
[283] G. Dorn,et al. Inhibition of ischemic cardiomyocyte apoptosis through targeted ablation of Bnip3 restrains postinfarction remodeling in mice. , 2007, The Journal of clinical investigation.
[284] B. Rothermel,et al. Autophagy in load-induced heart disease. , 2008, Circulation research.
[285] S. Delp,et al. Short Telomeres and Stem Cell Exhaustion Model Duchenne Muscular Dystrophy in mdx/mTR Mice , 2010, Cell.
[286] J. Stamler,et al. Convergence of G Protein–Coupled Receptor and S-Nitrosylation Signaling Determines the Outcome to Cardiac Ischemic Injury , 2013, Science Signaling.
[287] Michael E. Hall,et al. Systolic dysfunction in cardiac-specific ligand-inducible MerCreMer transgenic mice. , 2011, American journal of physiology. Heart and circulatory physiology.
[288] E. Levin,et al. Estrogen Prevents Cardiomyocyte Apoptosis through Inhibition of Reactive Oxygen Species and Differential Regulation of p38 Kinase Isoforms* , 2006, Journal of Biological Chemistry.
[289] Alan V. Smrcka,et al. Differential Targeting of Gßγ-Subunit Signaling with Small Molecules , 2006, Science.
[290] P. Ping,et al. Enhanced PKCβII translocation and PKCβII-RACK1 interactions in PKCε-induced heart failure: a role for RACK1 , 2001 .
[291] S. Knapp,et al. Mechanism and consequence of the autoactivation p38α Mitogen-activated Protein Kinase promoted by TAB1 , 2013, Nature Structural &Molecular Biology.
[292] PJ Willems,et al. Genetic factors in non‐syndromic congenital heart malformations , 2010, Clinical genetics.
[293] Nico Tjandra,et al. Structure of Bax Coregulation of Dimer Formation and Intracellular Localization , 2000, Cell.
[294] Gabriel Pineda,et al. Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. , 2006, Molecular cell.
[295] Xiaodong Wang,et al. Smac, a Mitochondrial Protein that Promotes Cytochrome c–Dependent Caspase Activation by Eliminating IAP Inhibition , 2000, Cell.
[296] T. Strandberg,et al. The roles of senescence and telomere shortening in cardiovascular disease , 2013, Nature Reviews Cardiology.
[297] J. Finsterer,et al. Treatment of dystrophin cardiomyopathies , 2014, Nature Reviews Cardiology.
[298] S. Burchill,et al. p38(MAPK): stress responses from molecular mechanisms to therapeutics. , 2009, Trends in molecular medicine.
[299] T. Tan,et al. A Novel Human STE20-related Protein Kinase, HGK, That Specifically Activates the c-Jun N-terminal Kinase Signaling Pathway* , 1999, The Journal of Biological Chemistry.
[300] H. Rakowski,et al. A CMR study of left atrial mechanics in hypertrophic cardiomyopathy: left atrial function predicts paroxysmal atrial fibrillation , 2013 .
[301] G. Dorn,et al. Additive Protection of the Ischemic Heart Ex Vivo by Combined Treatment With &dgr;-Protein Kinase C Inhibitor and &egr;-Protein Kinase C Activator , 2003 .
[302] J. Ornato,et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article , 2005 .
[303] G. Dorn,et al. Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts: critical role for expression level. , 2000, Circulation.
[304] W. Linke,et al. Telethonin Deficiency Is Associated With Maladaptation to Biomechanical Stress in the Mammalian Heart , 2011, Circulation research.
[305] J. Butler,et al. Heart Failure 2012 , 2012, Cardiology research and practice.
[306] L. Mestroni,et al. A point mutation in the 5' splice site of the dystrophin gene first intron responsible for X-linked dilated cardiomyopathy. , 1996, Human molecular genetics.
[307] Shih-Ann Chen,et al. Histone deacetylase inhibition improved cardiac functions with direct antifibrotic activity in heart failure. , 2013, International journal of cardiology.
[308] M. Marber,et al. New therapeutic targets in cardiology: p38 alpha mitogen-activated protein kinase for ischemic heart disease. , 2012, Circulation.
[309] K. Chien,et al. The MEKK-JNK Pathway Is Stimulated by α1-Adrenergic Receptor and Ras Activation and Is Associated with in Vitroand in Vivo Cardiac Hypertrophy* , 1997, The Journal of Biological Chemistry.
[310] M. Sano,et al. Cyclin-Dependent Kinase-9 An RNAPII Kinase at the Nexus of Cardiac Growth and Death Cascades , 2004 .
[311] Pierre Croisille,et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. , 2008, The New England journal of medicine.
[312] M. Lohse,et al. Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[313] Henrik Westerberg,et al. A comparative phenotypic and genomic analysis of C57BL/6J and C57BL/6N mouse strains , 2013, Genome Biology.
[314] W. Craigen,et al. Activation of cardiac Cdk9 represses PGC‐1 and confers a predisposition to heart failure , 2004, The EMBO journal.
[315] Michael D. Schneider,et al. Activation of Rho-associated coiled-coil protein kinase 1 (ROCK-1) by caspase-3 cleavage plays an essential role in cardiac myocyte apoptosis , 2006, Proceedings of the National Academy of Sciences.
[316] J. Metzger. Cardiac muscle regeneration , 1982 .
[317] A. Demetris,et al. Cardiac-specific overexpression of tumor necrosis factor-alpha causes lethal myocarditis in transgenic mice. , 1997, Journal of cardiac failure.
[318] Padmini Sarathchandra,et al. Cardiac fibrosis in mice expressing an inducible myocardial-specific Cre driver , 2013, Disease Models & Mechanisms.
[319] J. Molkentin,et al. TRPC Channels As Effectors of Cardiac Hypertrophy , 2011, Circulation research.
[320] G. Dorn,et al. Transgenic Galphaq overexpression induces cardiac contractile failure in mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[321] Ciro Indolfi,et al. Adult c-kitpos Cardiac Stem Cells Are Necessary and Sufficient for Functional Cardiac Regeneration and Repair , 2013, Cell.
[322] Michael D. Schneider,et al. Bcl-2 Antiapoptotic Proteins Inhibit Beclin 1-Dependent Autophagy , 2005, Cell.
[323] Dianqing Wu,et al. Differential targeting of Gbetagamma-subunit signaling with small molecules. , 2006, Science.
[324] Dian J. Cao,et al. Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy , 2011, Proceedings of the National Academy of Sciences.
[325] Thomas M. Keane,et al. Resource Genome Sequencing Reveals Loci under Artificial Selection that Underlie Disease Phenotypes in the Laboratory Rat , 2013 .
[326] G. Dorn,et al. Rescue of Contractile Parameters and Myocyte Hypertrophy in Calsequestrin Overexpressing Myocardium by Phospholamban Ablation* , 2001, The Journal of Biological Chemistry.
[327] G. Taffet,et al. Bcl-2 overexpression corrects mitochondrial defects and ameliorates inherited desmin null cardiomyopathy. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[328] R. Kitsis,et al. A mechanistic role for cardiac myocyte apoptosis in heart failure. , 2003, The Journal of clinical investigation.
[329] G. Boivin,et al. A familial hypertrophic cardiomyopathy alpha-tropomyosin mutation causes severe cardiac hypertrophy and death in mice. , 2001, Journal of molecular and cellular cardiology.
[330] K. Das,et al. Protein kinase C, an elusive therapeutic target? , 2012, Nature Reviews Drug Discovery.
[331] B. Gersh,et al. Infarct size after acute myocardial infarction measured by quantitative tomographic 99mTc sestamibi imaging predicts subsequent mortality. , 1995, Circulation.
[332] Lei Shi,et al. Structural and Dynamic Basis of Phospholamban and Sarcolipin Inhibition of , 2008 .
[333] P. Powers,et al. Cardiac troponin I gene knockout: a mouse model of myocardial troponin I deficiency. , 1999, Circulation research.
[334] A. Ibrahim,et al. Acute myocardial infarction. , 2014, Critical care clinics.
[335] D. Goeddel,et al. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. , 1998, Science.
[336] T. Hewett,et al. PKC-α regulates cardiac contractility and propensity toward heart failure , 2004, Nature Medicine.
[337] R. Kitsis,et al. Ubiquitination and Degradation of the Anti-apoptotic Protein ARC by MDM2* , 2007, Journal of Biological Chemistry.
[338] S. Silver,et al. Heart Failure , 1937, The New England journal of medicine.
[339] E. Niggli,et al. Cardiac phenotype of Duchenne Muscular Dystrophy: insights from cellular studies. , 2013, Journal of molecular and cellular cardiology.
[340] F. Muntoni,et al. The absence of dystrophin brain isoform expression in healthy human heart ventricles explains the pathogenesis of 5' X-linked dilated cardiomyopathy , 2012, BMC Medical Genetics.
[341] Yibin Wang,et al. Role of an alternatively spliced form of alphaII-spectrin in localization of connexin 43 in cardiomyocytes and regulation by stress-activated protein kinase. , 2007, Journal of molecular and cellular cardiology.
[342] Michael D. Schneider,et al. A pivotal role for endogenous TGF-β-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway , 2006, Proceedings of the National Academy of Sciences.
[343] Kalyani V. P. Guntur,et al. Tumor Necrosis Factor α (TNFα) Stimulates Map4k4 Expression through TNFα Receptor 1 Signaling to c-Jun and Activating Transcription Factor 2* , 2007, Journal of Biological Chemistry.
[344] G. Dorn,et al. Mouse Model of Desmin-Related Cardiomyopathy , 2001, Circulation.
[345] J. Gummert,et al. Inhibition of Elevated Ca2+/Calmodulin-Dependent Protein Kinase II Improves Contractility in Human Failing Myocardium , 2010, Circulation research.
[346] C. Baines. The mitochondrial permeability transition pore as a target of cardioprotective signaling. , 2007, American journal of physiology. Heart and circulatory physiology.
[347] Xiaoqing Tang,et al. An RNA interference-based screen identifies MAP4K4/NIK as a negative regulator of PPARγ, adipogenesis, and insulin-responsive hexose transport , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[348] V. Kytö,et al. Apoptotic cardiomyocyte death in fatal myocarditis. , 2004, The American journal of cardiology.